FindTrial
Sign In

Incidence of anti-COVID-19 IgM and IgG in asymptomatic gastroenterological care workers

Incidence of anti-COVID-19 IgM and IgG in asymptomatic gastroenterological care workers - Anti-COVID-19 antibodies in gastroenterological care workers

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50117
Enrollment
100
Registered
2020-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona virus COVID-19

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: People working at the endoscopy department of the Erasmus Medical Center can only be included. They have been working at the endoscopy department in the last two weeks.

Exclusion criteria

Exclusion criteria: Not working (anymore) at the endoscopy department

Design outcomes

Primary

MeasureTime frame
Number of workers with a positive COVID-19 finger prick blood test for IgM and/or IgG antibodies.—

Secondary

MeasureTime frame
- Number of subjects developing COVID-19 IgM and/or IgG antibodies during the study period - Number of subjects with physical complaints and a positive finger prick test - Number of subjects with physical complaints and a negative finger prick test—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)